Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophagogastric Cancer × zirconium-89-trastuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 HER2-positive Solid Tumor 1 Esophagogastric Cancer 1 Breast Cancer Metastases 1

Interventions

zirconium-89-trastuzumab 1 STA 9090 1 Positron-Emission Tomography 1 Pemetrexed 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02023996 2024-12-10

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed

42 enrolled 11 charts

Gastrointestinal

Esophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡